AhR Agonists

Cat.No. Product Name Information Product Use Citations Product Validations
S7711 CH-223191 CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist with IC50 of 30 nM.
Cells, 2025, 14(8)605
Chem Biol Interact, 2025, 412:111478
Front Nutr, 2025, 12:1500293
Verified customer review of CH-223191
S2858 Stemregenin 1 (SR1) StemRegenin 1 (SR1) is an aryl hydrocarbon receptor (AhR) inhibitor with IC50 of 127 nM in a cell-free assay.
Cell, 2025, S0092-8674(25)01149-3
Nat Commun, 2025, 16(1):2384
Cell Rep Med, 2025, 6(8):102297
Verified customer review of Stemregenin 1 (SR1)
S8995 BAY 2416964 BAY 2416964 (compound 192) is a potent and orally active antagonist of aryl hydrocarbon receptor (AhR) with an IC50 of 341 nM. This compound has the potential in the treatment of solid tumours.
Ecotoxicol Environ Saf, 2025, 290:117743
JBMR Plus, 2025, 9(6):ziaf067
NAR Genom Bioinform, 2025, 7(2):lqaf052
S6560 PDM2 PDM2 is a potent and selective aryl hydrocarbon receptor (AhR) antagonist.
Cancer Cell Int, 2021, 21(1):538
S6926 GNF351 GNF351 is a potent antagonist of the aryl hydrocarbon receptor (AHR). This compound interacts directly with the AHR ligand binding pocket and competes with a well-characterised photoaffinity AHR ligand for binding to the AHR with an IC50 of 62 nM.
Front Pharmacol, 2021, 12:655281
S0155 PDM-11 PDM-11 is a derivative of resveratrol that exhibits stronger antagonist affinity for arylhydrocarbon receptors (AhR) than resveratrol, without any affinity for the estrogen receptor.
S1177 PD 98059 PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 μM in a cell-free assay, specifically inhibits MEK-1-mediated activation of MAPK; does not directly inhibit ERK1 or ERK2. PD98059 is a ligand for the aryl hydrocarbon receptor (AHR) and functions as an AHR antagonist.
Nat Commun, 2025, 16(1):212
Adv Sci (Weinh), 2025, 12(28):e2502634
Theranostics, 2025, 15(6):2624-2648
Verified customer review of PD 98059